[go: up one dir, main page]

GB201312128D0 - Drug combination and its use in therapy - Google Patents

Drug combination and its use in therapy

Info

Publication number
GB201312128D0
GB201312128D0 GBGB1312128.0A GB201312128A GB201312128D0 GB 201312128 D0 GB201312128 D0 GB 201312128D0 GB 201312128 A GB201312128 A GB 201312128A GB 201312128 D0 GB201312128 D0 GB 201312128D0
Authority
GB
United Kingdom
Prior art keywords
therapy
drug combination
drug
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1312128.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Cambridge Ltd
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Priority to GBGB1312128.0A priority Critical patent/GB201312128D0/en
Publication of GB201312128D0 publication Critical patent/GB201312128D0/en
Priority to PCT/GB2014/052048 priority patent/WO2015001358A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1312128.0A 2013-07-05 2013-07-05 Drug combination and its use in therapy Ceased GB201312128D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1312128.0A GB201312128D0 (en) 2013-07-05 2013-07-05 Drug combination and its use in therapy
PCT/GB2014/052048 WO2015001358A1 (en) 2013-07-05 2014-07-04 Drug combination and its use in therapy of obesity and type ii diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1312128.0A GB201312128D0 (en) 2013-07-05 2013-07-05 Drug combination and its use in therapy

Publications (1)

Publication Number Publication Date
GB201312128D0 true GB201312128D0 (en) 2013-08-21

Family

ID=49033419

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1312128.0A Ceased GB201312128D0 (en) 2013-07-05 2013-07-05 Drug combination and its use in therapy

Country Status (2)

Country Link
GB (1) GB201312128D0 (en)
WO (1) WO2015001358A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2498757A1 (en) * 2009-11-13 2012-09-19 Bristol-Myers Squibb Company Reduced mass metformin formulations

Also Published As

Publication number Publication date
WO2015001358A1 (en) 2015-01-08

Similar Documents

Publication Publication Date Title
IL304851A (en) Tazemetostat in combination with a standard care agent for use in the treatment of cancer
IL242610A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
GB201320729D0 (en) Therapeutic compounds and their use
PL2999711T3 (en) Polymyxin derivatives and their use in combination therapy together with different antibiotics
GB201319621D0 (en) Antimicrobial agents and their use in therapy
ZA201505735B (en) Cancer drug and uses
LT3065759T (en) Immunosuppressive agents and their use in therapy
PL3004112T3 (en) Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
IL239904A0 (en) Inhibitory oligonucleotides and their use in therapy
GB201311361D0 (en) Compounds and their therapeutic use
GB2515865B (en) Use of galactooligosaccharides in therapy
GB201604213D0 (en) Drug combination and its use in therapy
ZA201607581B (en) Dosage forms and therapeutic uses l-4lchlorokynurenine
GB201310921D0 (en) Peptide-resin conjugate and use thereof
GB201308736D0 (en) Compounds and their therapeutic use
GB201308753D0 (en) Compounds and their use in therapy
GB201308217D0 (en) Compounds and their use in therapy
GB201322869D0 (en) Therapeutic agents and delivery with microspheres
HUE036306T2 (en) Use of odiparcil in the treatment of mucopolysaccharidosis
GB201312131D0 (en) Drug combination and its use in therapy
GB201312128D0 (en) Drug combination and its use in therapy
GB201312129D0 (en) Drug combination and its use in therapy
AU2013901916A0 (en) An Agent and Use Thereof in Therapy
EP3071207A4 (en) Libido-enhancing therapeutic and use
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)